メインナビゲーションにスキップ 検索にスキップ メインコンテンツにスキップ

Kynureninase deficiency ameliorated monocytic recruitment and severity in a mouse model of multiple sclerosis

研究成果: ジャーナルへの寄稿 › 学術論文 › 査読

抄録

Multiple sclerosis (MS) is a common autoimmune demyelinating disease of the central nervous system (CNS). Although activation of the kynurenine (KYN) pathway has been observed in patients with MS, its pathological significance remains unclear. In this study, we investigated the role of the KYN pathway in MS using an experimental autoimmune encephalomyelitis (EAE) mouse model, a widely recognized animal model of MS. We found an increase in the expression of kynureninase (KYNU), a key enzyme in the KYN pathway that is specifically localized within monocytes in the spinal cord of EAE mice. This was accompanied by a significant accumulation of quinolinic acid (QUIN) in the spinal cord. Importantly, similar increases in KYNU expression and QUIN levels were observed in the spinal cord of proteolipid protein overexpressing mice (PLP-tg mice), another model of demyelination. Notably, KYNU knockout (KO) reduced EAE severity and monocyte recruitment to the spinal cord of EAE model mice. These findings suggest that the increase in KYNU expression and the subsequent accumulation of QUIN may contribute to the exacerbation of MS. Taken together, our results indicate that KYNU could be a novel therapeutic target for MS.

本文言語英語
論文番号106141
ジャーナルNeurochemistry International
巻195
DOI
出版ステータス出版済み - 05-2026

All Science Journal Classification (ASJC) codes

  • 細胞および分子神経科学
  • 細胞生物学

フィンガープリント

「Kynureninase deficiency ameliorated monocytic recruitment and severity in a mouse model of multiple sclerosis」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル